In our study, we prospectively enrolled Asians, particularly Korean T1DM patients who were CGM users, and used strict inclusion criteria of T1DM using not only diagnostic codes but also C-peptide levels, autoantibodies, and consistent insulin use. The gene discussed is INS; the disease is type 1 diabetes mellitus.